首页> 外文期刊>Acta Neurochirurgica >Intra-operative MRI vs endoscopy in achieving gross total resection of pituitary adenomas: a systematic review
【24h】

Intra-operative MRI vs endoscopy in achieving gross total resection of pituitary adenomas: a systematic review

机译:术中MRI对内镜检查垂直切除总腺瘤的总切除术:系统审查

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundIntraoperative magnetic resonance imaging (iMRI) is a technology that may improve rates of gross total resection (GTR) for pituitary adenomas. The endoscope is another less expensive technology, which also may maximize resection rates. A direct comparison of these approaches and their additive benefit has never been performed.MethodsA systematic review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) standard. PubMed and Embase databases were searched for studies that examined GTR for pituitary adenoma resection with either endoscopic transsphenoidal surgery (eTSS), microscopic transsphenoidal surgery with iMRI (mTSS + iMRI), or endoscopic transsphenoidal surgery with iMRI (eTSS + iMRI).ResultsEighty-five studies that reported GTR rates in 7124 pituitary adenoma patients were identified. For all pituitary adenomas, eTSS had a pooled proportion of GTR of 68.9% (95% CI 64.7-73.0%) which was similar to that of mTSS + iMRI (GTR 68.3%; 95% CI=59.4-76.5%) and eTSS + iMRI (GTR 70.7%; 95% CI=56.9-89.6%). For the subgroup of pituitary macroadenomas, pooled proportions for GTR were similar between eTSS and mTSS + iMRI (eTSS: GTR 59.4%; 95% CI=49.6-68.7% vs mTSS + iMRI: GTR 68.8%; 95% CI=57.3-79.3%), and higher for eTSS + iMRI (81.1%; 95% CI=75.5-86.2%). The post-operative CSF leak proportion for eTSS (4.7%; 95% CI=3.6-5.9%) was similar to that for eTSS + iMRI (3.7%; 95% CI=1.6-6.5%) and mTSS + iMRI (4.6%; 95% CI=2.0-8.3%). No direct statistical comparisons could be performed.ConclusionFinal GTR proportions are similar whether the surgeon uses a microscope supplemented with iMRI or endoscope with or without iMRI. The benefit of the two technologies may be complementary for macroadenomas. These findings are important to consider when comparing the efficacy of different technical strategies in the management of pituitary adenomas.
机译:背景结果磁共振成像(IMRI)是一种可以提高垂体腺瘤总切除率(GTR)的技术。内窥镜是另一种较便宜的技术,也可能最大化切除率。从未进行过这些方法的直接比较和它们的添加剂益处..在系统评价和荟萃分析(PRISMA)标准的首选报告项目中进行了一项系统审查。搜索了PUBMED和EMBASE数据库的研究,用于研究用内镜晶状体手术(ETES),与IMRI(MTSS + IMRI)的微观晶状体手术,与IMRI(ETSS + IMRI)的内窥镜晶状体手术进行垂体腺瘤切除的研究.Resultseighty-5鉴定了7124例垂体腺瘤患者的GTR率的研究。对于所有垂体腺瘤,ETS具有68.9%的汇集比例,68.9%(95%CI 64.7-73.0%类似,其与MTSS + IMRI(GTR 68.3%; 95%CI = 59.4-76.5%)和ETSS +相似IMRI(GTR 70.7%; 95%CI = 56.9-89.6%)。对于垂体宏观罗纳麦组织的亚组,ETS和MTSS + IMRI之间的GTR汇总比例在ETS和MTSS + IMRI之间(ETSS:GTR 59.4%; 95%CI = 49.6-68.7%VS MTSS + IMRI:GTR 68.8%; 95%CI = 57.3-79.3 %),ETSS + IMRI更高(81.1%; 95%CI = 75.5-86.5%)。 ETS的术后CSF泄漏比例(4.7%; 95%CI = 3.6-5.9%类似于ETS + IMRI(3.7%; 95%CI = 1.6-6.5%)和MTSS + IMRI(4.6% ; 95%CI = 2.0-8.3%)。无直接统计比较可以进行.ConclusionFinal GTR比例是类似的外科医生使用辅用IMRI或内窥镜的显微镜,有或没有IMRI。两种技术的好处可能是Macroadenomas的互补。当比较不同技术策略在垂体腺瘤管理中的疗效时,这些发现很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号